Skip to main content
SpringerLink
Log in

RCT mit 5-FU und Mitomycin C mit 28 Fraktionen á 1,8 Gy einer externen Strahlentherapie bleibt Behandlungsstandard beim Analkarzinom

RCT with 5-FU and mitomycin C with 28 fractions of 1.8 Gy external radiotherapy remains standard treatment of squamous-cell carcinoma of the anus

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914–1921

    Article  PubMed  CAS  Google Scholar 

  2. o A (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348:1049–1054 (No authors listed)

    Article  Google Scholar 

  3. Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539

    PubMed  CAS  Google Scholar 

  4. Grabenbauer GG, Kessler H, Matzel KE et al (2005) Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 48:1742–1751

    Article  PubMed  Google Scholar 

  5. Gunderson LL, Winter KA, Ajani JA et al (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 30:4344–4351

    Article  PubMed  CAS  Google Scholar 

  6. James RD, Glynne-Jones R, Meadows HM et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14:516–524

    Article  PubMed  CAS  Google Scholar 

  7. Peiffert D, Tournier-Rangeard L, Gérard JP et al (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30:1941–1948

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlentherapie und Radioonkologie, Klinikum Coburg, Ketschendorfer Str. 33, 96450, Coburg, Deutschland

    G.G. Grabenbauer

Authors
  1. G.G. Grabenbauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G.G. Grabenbauer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grabenbauer, G. RCT mit 5-FU und Mitomycin C mit 28 Fraktionen á 1,8 Gy einer externen Strahlentherapie bleibt Behandlungsstandard beim Analkarzinom. Strahlenther Onkol 189, 982–983 (2013). https://doi.org/10.1007/s00066-013-0448-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0448-5

Search

Navigation